[Federal Register Volume 65, Number 186 (Monday, September 25, 2000)]
[Notices]
[Pages 57623-57624]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-24562]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 12, 2000, and published in the Federal Register 
on June 2, 2000, (65 FR 35397), Sigma Aldrich Research Biochemicals, 
Inc., Attn: Richard Milius, 1-3 Strathmore Road, Natick, Massachusetts 
01760, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
Aminorex (1585)............................  I
Alpha-Ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
4-Bromo-2, 5-dimethoxyam-..................  I
phetamine (7391)...........................
4-Bromo-2, 5-dimethoxyphen-................  I
ethylamine (7392)..........................
2, 5-Dimethoxyamphetamine (7396)...........  I
3, 4-Methylendioxyamphetamine (7400).......  I
N-Hydroxy-3, 4-methylenedioxy-.............  I
amphetamine (7402).........................
3, 4-Methylenedioxy-N-ethylam-.............  I
phetamine (7404)...........................
3,4-Methylenedioxymethamphetamine (7405)...  I
Psilocybin (7437)..........................  I
1-[1- (2-Thienyl)cyclo-....................  I
hexyl]piperidine (7470)....................
Heroin (9200)..............................  I
Normorphine (9313).........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Pentobarbital (2270).......................  II
Phenylcyclohexylamine (7460)...............  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codenine (9050)............................  II
Diprenorphine (9058).......................  II
Benzoylecgonine (9180).....................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Meperidine (9230)..........................  II
Metazocine (924)...........................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Levo-alphacetylmethadol (LAAM) (9648)......  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
laboratory reference standards and neurochemicals.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Sigma Aldrich 
Research Biochemicals, Inc. to manufacture the listed controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Sigma Aldrich Research Biochemicals, Inc. on a regular 
basis to ensure that the company's continued registration is consistent 
with the public interest. These investigations have included

[[Page 57624]]

inspection and testing of the company's physical security systems, 
audits of the company's records, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic classes 
of controlled substances listed above is granted.

    August 18, 2000.
John H. King,
Deputy Assistant Administrator Office of Diversion Control Drug 
Enforcement Administration.
[FR Doc. 00-24562 Filed 9-22-00; 8:45 am]
BILLING CODE 4410-09-M